Claude creates protein binders to neutralize scorpion neurotoxins
claude protein
| Source: HN | Original article
An internal Claude AI model has engineered minibinder proteins that tightly attach to scorpion neurotoxins.
Anthropic’s internal Claude model has produced the first AI‑designed protein binders that work against lethal scorpion neurotoxins. In a 64‑hour autonomous run, the research‑grade Claude generated 318,484 minibinder designs and screened more than half a million design‑toxin pairings using twelve in‑house tools. From 211 candidates tested in the lab, 17 showed measurable binding to five different scorpion toxins, and two of the Cn2 binders reached single‑digit nanomolar affinity.
The achievement matters because scorpion envenomation remains a neglected tropical disease, claiming over 3,250 lives annually. Current antivenoms are derived from animal serum, a process that is slow, costly and fraught with supply constraints. By automating the early stages of protein design, Claude compresses what would traditionally take months of iterative laboratory work into a few days, potentially opening a faster, more scalable path to next‑generation antivenoms.
What to watch next is whether the promising binders can be further optimized and moved into pre‑clinical testing. Anthropic’s approach—one initial prompt followed by four follow‑up directives, with Claude setting its own quality thresholds—suggests a template that could be applied to other venomous species or even broader therapeutic targets. Success in scaling the workflow could reshape how biotech firms tackle high‑risk, low‑profit diseases, and it will be telling to see if the model’s autonomy is expanded beyond design to include downstream validation steps. The next milestones will likely involve detailed affinity maturation, safety profiling, and collaborations with antivenom manufacturers.
Sources
Back to AIPULSEN